BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9413707)

  • 1. Metrifonate. A viewpoint.
    Giacobini E
    Drugs Aging; 1997 Dec; 11(6):497. PubMed ID: 9413707
    [No Abstract]   [Full Text] [Related]  

  • 2. Metrifonate. A viewpoint.
    Taylor P
    Drugs Aging; 1997 Dec; 11(6):497. PubMed ID: 9413708
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of metrifonate on extracellular brain acetylcholine and object recognition in aged rats.
    Scali C; Giovannini MG; Bartolini L; Prosperi C; Hinz V; Schmidt B; Pepeu G
    Eur J Pharmacol; 1997 May; 325(2-3):173-80. PubMed ID: 9163564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metrifonate: overview of safety and efficacy.
    Cummings JL
    Pharmacotherapy; 1998; 18(2 Pt 2):43-6; discussion 79-82. PubMed ID: 9543464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alzheimer disease. Irreversible AChE inhibition with metrifonate].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 1998 Aug; 21(8):250. PubMed ID: 9758555
    [No Abstract]   [Full Text] [Related]  

  • 6. Metrifonate for Alzheimer's disease: is the next cholinesterase inhibitor better?
    Sandson TA
    Neurology; 1999 Feb; 52(3):675-6. PubMed ID: 10025821
    [No Abstract]   [Full Text] [Related]  

  • 7. Metrifonate for Alzheimer's disease: is the next cholinesterase inhibitor better?
    Knopman DS
    Neurology; 1998 May; 50(5):1203-5. PubMed ID: 9595961
    [No Abstract]   [Full Text] [Related]  

  • 8. Metrifonate: update on a new antidementia agent.
    Ringman JM; Cummings JL
    J Clin Psychiatry; 1999 Nov; 60(11):776-82. PubMed ID: 10584768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of subchronic treatment with metrifonate and tacrine on brain cholinergic function in aged F344 rats.
    Giovannini MG; Scali C; Bartolini L; Schmidt B; Pepeu G
    Eur J Pharmacol; 1998 Jul; 354(1):17-24. PubMed ID: 9726626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metrifonate effects on acetylcholine and biogenic amines in rat cortex.
    Mori F; Cuadra G; Giacobini E
    Neurochem Res; 1995 Sep; 20(9):1081-8. PubMed ID: 8570013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metrifonate for Alzheimer's disease patients.
    Schneider LS
    J Clin Psychiatry; 2000 Mar; 61(3):218-9. PubMed ID: 10817111
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats.
    Scali C; Casamenti F; Bellucci A; Costagli C; Schmidt B; Pepeu G
    J Neural Transm (Vienna); 2002 Jul; 109(7-8):1067-80. PubMed ID: 12111444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of metrifonate on memory impairment and cholinergic dysfunction in rats.
    Itoh A; Nitta A; Katono Y; Usui M; Naruhashi K; Iida R; Hasegawa T; Nabeshima T
    Eur J Pharmacol; 1997 Mar; 322(1):11-9. PubMed ID: 9088864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of metrifonate on blood cholinesterases in children during the treatment of schistosomiasis.
    Davis RP; Bailey DR
    Bull World Health Organ; 1972; 46(6):747-59. PubMed ID: 4538536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metrifonate.
    Lamb HM; Faulds D
    Drugs Aging; 1997 Dec; 11(6):490-6. PubMed ID: 9413706
    [No Abstract]   [Full Text] [Related]  

  • 16. The pharmacological basis for metrifonate's favourable tolerability in the treatment of Alzheimer's disease.
    Schmidt BH; Heinig R
    Dement Geriatr Cogn Disord; 1998; 9 Suppl 2():15-9. PubMed ID: 9718230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical pharmacology of metrifonate.
    Jann MW
    Pharmacotherapy; 1998; 18(2 Pt 2):55-67; discussion 79-82. PubMed ID: 9543466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of the schistosomicidal activity of an organophosphorus compound, metrifonate, in urinary bilharziasis].
    Gentilini M; Danis M; Houenassou P; Arnaud JP
    Bull Soc Pathol Exot Filiales; 1973; 66(2):299-306. PubMed ID: 4209135
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluating response to metrifonate.
    Tariot PN
    J Clin Psychiatry; 1998; 59 Suppl 9():33-7. PubMed ID: 9720485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of metrifonate on cognitive decline in Alzheimer disease: a double-blind, placebo-controlled, 6-month study.
    Becker RE; Colliver JA; Markwell SJ; Moriearty PL; Unni LK; Vicari S
    Alzheimer Dis Assoc Disord; 1998 Mar; 12(1):54-7. PubMed ID: 9539412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.